EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Short-Term Immunogenicity of Licensed Subunit RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) Compared to Community-Dwelling Older Adults

Ann R Falsey, Angela R Branche, Michael Peasley, Mary Cole, Kim K Petrone, Spencer Obrecht, Kari Steinmetz, Tanya Smith, Alexis Owen, Christopher S Anderson, Clyde Overby, Derick R Peterson und 1 weitere

Journal of the American Medical Directors Association · 2024

DOI: 10.1016/j.jamda.2024.105281 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Medical Directors Association, 2024. Verfasst von Ann R Falsey und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. Electronic address: ann_falsey@urmc.ro…. Hauptthemen laut MEDLINE: Long-Term Care, Respiratory Syncytial Virus Vaccines, Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID DMID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Phase 3 licensing trials for the recently approved respiratory syncytial virus (RSV) vaccines did not include many residents of long-term care facilities (LTCF). Our primary objective was to assess humoral immune responses in LTCF residents, aged 60 and older, to the RSV vaccines, and demonstrate noninferiority to antibody responses in community-dwelling (CD) adults who were representative of the phase 3 trial participants in whom the vaccines were highly efficacious. DESIGN: Prospective non-randomized intervention trial of RSV vaccines in LTCF residents. SETTING AND PARTICIPANTS: Research clinic and 2 LTCFs. Adults aged ≥60 years old, free of immunosuppression and planning to receive an RSV vaccine were eligible. METHODS: LTCF and CD participants received either the GSK or Pfizer RSV vaccine in equal numbers. Blood was collected before and 30 days after vaccination. Total immunoglobulin (Ig)G to the prefusion F protein of RSV group A (FA) and B (FB), and neutralizing activity were measured, and geometric mean titer (GMT) and geometric mean fold rise (GMFR) calculated. Intercurrent respiratory illnesses were tracked. RESULTS: A total of 76 LTCF residents and 76 CD adults were enrolled. Day 30 blood was unavailable from 3 residents and 3 had RSV infection and vaccination was deferred, leaving data for 76 CD and 70 LTCF adults for analysis. Serum IgG GMFR prefusion FA (9.9 vs 12.5, P = .14), prefusion FB (8.7 vs 11.0, P = .17) were not statistically different in CD and LTCF cohorts, respectively, and also equivalent for GMFR in viral neutralization titers (12.8 vs. 15.5, P = .32). As measured by GMT or GMFR, RSV vaccine responses of LTCF residents met noninferiority criteria compared with the CD cohort. CONCLUSIONS AND IMPLICATIONS: This small immunobridging study demonstrates robust antibody responses to RSV vaccines in LTCF residents providing support for their use in this high-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Long-Term CareRespiratory Syncytial Virus VaccinesRespiratory Syncytial Virus InfectionsHumansMaleFemaleAgedProspective StudiesMiddle AgedAged, 80 and overVaccines, SubunitAntibodies, ViralIndependent LivingImmunogenicity, Vaccine

Stichwörter der Autor:innen

Respiratory syncytial virusimmune responselong-term care facilitiesvaccine

Substanzen

Respiratory Syncytial Virus VaccinesVaccines, SubunitAntibodies, Viral

Autor:innen und Institutionen

  • Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. Electronic address: ann_falsey@urmc.rochester.edu.
  • Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
  • Infection Prevention Department, The Highlands at Brighton, Rochester, NY, USA.
  • St Ann's Community, Rochester, NY, USA.
  • Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Förderung

  • NIAID DMID

Zitieren

APA

Falsey, A. R., Branche, A. R., Peasley, M., Cole, M., Petrone, K. K., Obrecht, S., Steinmetz, K., Smith, T., Owen, A., Anderson, C. S., Overby, C., Peterson, D. R., & Walsh, E. E. (2024). Short-Term Immunogenicity of Licensed Subunit RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) Compared to Community-Dwelling Older Adults. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2024.105281

Vancouver

Falsey AR, Branche AR, Peasley M, Cole M, Petrone KK, Obrecht S, et al. Short-Term Immunogenicity of Licensed Subunit RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) Compared to Community-Dwelling Older Adults. Journal of the American Medical Directors Association. 2024. doi:10.1016/j.jamda.2024.105281

BibTeX
@article{Falsey2024,
  author = {Falsey, Ann R and Branche, Angela R and Peasley, Michael and Cole, Mary and Petrone, Kim K and Obrecht, Spencer and Steinmetz, Kari and Smith, Tanya and Owen, Alexis and Anderson, Christopher S and Overby, Clyde and Peterson, Derick R and Walsh, Edward E},
  title = {Short-Term Immunogenicity of Licensed Subunit RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) Compared to Community-Dwelling Older Adults},
  journal = {Journal of the American Medical Directors Association},
  year = {2024},
  doi = {10.1016/j.jamda.2024.105281}
}
Kostenlos starten →